Results
BioMarin Q1 2026 Beats Forecasts, Stock Slides 1.5%
BioMarin posted Q1 2026 EPS $0.76 vs $0.74 forecast and revenue $766 million vs $755.94 million expected.
Despite the beat, shares fell 1.52% in after‑hours trading, closing at $53.24.
Updated full‑ye
